Last updated on March 2019

Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced PCD

Brief description of study

Assessment of QOL and symptoms changes in primary or secondary, unilateral or bilateral lower extremity patients using an advanced pneumatic compression system.

Detailed Study Description

Multi-centered, single arm, observational clinical trial of a prospective cohort of an estimated 300 participants with primary or secondary, unilateral or bilateral, lower extremity lymphedema. All participants receive intermittent pneumatic compression treatment for 52 weeks. Quality of life and symptoms will be assessed pre- and post - intermittent pneumatic compression treatment at 12, 24 and 52 weeks.

Clinical Study Identifier: NCT02661646

Find a site near you

Start Over